Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

GeneDx Holdings (WGS) Equity Ratio (2020 - 2026)

GeneDx Holdings has reported Equity Ratio over the past 7 years, most recently at 0.5 for Q1 2026.

  • Quarterly Equity Ratio fell 12.95% to 0.5 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was 0.5 through Mar 2026, down 12.95% year-over-year, with the annual reading at 0.59 for FY2025, 0.63% up from the prior year.
  • Equity Ratio was 0.5 for Q1 2026 at GeneDx Holdings, down from 0.59 in the prior quarter.
  • Over five years, Equity Ratio peaked at 0.68 in Q2 2022 and troughed at 0.5 in Q2 2024.
  • The 5-year median for Equity Ratio is 0.59 (2025), against an average of 0.58.
  • The largest YoY upside for Equity Ratio was 126.74% in 2022 against a maximum downside of 26.22% in 2022.
  • A 5-year view of Equity Ratio shows it stood at 0.52 in 2022, then increased by 5.37% to 0.54 in 2023, then increased by 7.4% to 0.58 in 2024, then rose by 0.63% to 0.59 in 2025, then decreased by 14.71% to 0.5 in 2026.
  • Per Business Quant, the three most recent readings for WGS's Equity Ratio are 0.5 (Q1 2026), 0.59 (Q4 2025), and 0.59 (Q3 2025).